Lerasan, Shiela Mae .

HRN: 16-91-34  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2025
AMPICILLIN 1GM (VIAL)
05/31/2025
06/03/2025
IV
2 G
Q6
PROM
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines